Rice Hall James & Associates LLC Has $2.55 Million Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

Rice Hall James & Associates LLC boosted its holdings in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 19.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 91,500 shares of the technology company's stock after purchasing an additional 14,871 shares during the quarter. Rice Hall James & Associates LLC owned approximately 0.46% of Simulations Plus worth $2,552,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. First Horizon Advisors Inc. boosted its holdings in Simulations Plus by 82.6% in the third quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company's stock worth $26,000 after purchasing an additional 370 shares during the period. Pitcairn Co. boosted its holdings in Simulations Plus by 9.1% in the third quarter. Pitcairn Co. now owns 6,599 shares of the technology company's stock worth $211,000 after purchasing an additional 549 shares during the period. Franklin Resources Inc. boosted its holdings in Simulations Plus by 7.6% in the third quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company's stock worth $342,000 after purchasing an additional 766 shares during the period. nVerses Capital LLC boosted its holdings in shares of Simulations Plus by 1,100.0% during the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company's stock valued at $38,000 after acquiring an additional 1,100 shares during the period. Finally, US Bancorp DE boosted its holdings in shares of Simulations Plus by 37.0% during the third quarter. US Bancorp DE now owns 4,974 shares of the technology company's stock valued at $159,000 after acquiring an additional 1,343 shares during the period. Institutional investors and hedge funds own 78.08% of the company's stock.

Simulations Plus Trading Down 0.2 %

SLP stock traded down $0.07 during trading on Friday, hitting $31.77. The company had a trading volume of 197,322 shares, compared to its average volume of 261,504. The business has a 50 day moving average of $31.69 and a 200 day moving average of $32.19. Simulations Plus, Inc. has a fifty-two week low of $24.00 and a fifty-two week high of $51.22. The firm has a market capitalization of $638.26 million, a price-to-earnings ratio of 79.43 and a beta of 0.83.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $33.91, for a total value of $678,200.00. Following the sale, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 19.40% of the stock is owned by company insiders.

Analyst Ratings Changes

SLP has been the subject of several analyst reports. StockNews.com downgraded shares of Simulations Plus from a "hold" rating to a "sell" rating in a report on Monday, November 4th. KeyCorp boosted their price target on shares of Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a report on Friday, January 24th. William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. BTIG Research reduced their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, October 24th. Finally, Stephens initiated coverage on shares of Simulations Plus in a report on Friday, November 15th. They issued an "overweight" rating and a $39.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $49.40.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.